Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Pituitary
|
January 9, 2020
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion
Ken K Y Ho, Maria Fleseriu, John Wass, et al.
Journal of the Endocrine Society
|
November 29, 2024
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol
John Newell-Price, Maria Fleseriu, Rosario Pivonello, et al.
The American Journal of Surgical Pathology
|
November 1, 2018
Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease
Sylvia L Asa, Shereen Ezzat, Daniel F Kelly, et al.
European Journal of Endocrinology
|
October 17, 2022
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes
Maria Fleseriu, Richard J Auchus, Yona Greenman, et al.
Biomedicines
|
November 11, 2022
Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib
Dongyun Zhang, William Yong, Masoud Movassaghi, et al.
European Journal of Endocrinology
|
June 12, 2025
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas
Gerald Raverot, Pia Burman, Ana Paula Abreu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 10, 2022
Treatment of Cushing Disease With Pituitary-Targeting Seliciclib
Ning-Ai Liu, Anat Ben-Shlomo, John D Carmichael, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 24, 2022
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease
Mônica Gadelha, Marie Bex, Richard A Feelders, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are Implemented
Jeremie Calais, Johannes Czernin, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A Hope, Emily K Bergsland, Murat Fani Bozkurt, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Pituitary
|
January 9, 2020
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion
Ken K Y Ho, Maria Fleseriu, John Wass, et al.
Journal of the Endocrine Society
|
November 29, 2024
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol
John Newell-Price, Maria Fleseriu, Rosario Pivonello, et al.
The American Journal of Surgical Pathology
|
November 1, 2018
Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease
Sylvia L Asa, Shereen Ezzat, Daniel F Kelly, et al.
European Journal of Endocrinology
|
October 17, 2022
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes
Maria Fleseriu, Richard J Auchus, Yona Greenman, et al.
Biomedicines
|
November 11, 2022
Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib
Dongyun Zhang, William Yong, Masoud Movassaghi, et al.
European Journal of Endocrinology
|
June 12, 2025
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas
Gerald Raverot, Pia Burman, Ana Paula Abreu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 10, 2022
Treatment of Cushing Disease With Pituitary-Targeting Seliciclib
Ning-Ai Liu, Anat Ben-Shlomo, John D Carmichael, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 24, 2022
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease
Mônica Gadelha, Marie Bex, Richard A Feelders, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are Implemented
Jeremie Calais, Johannes Czernin, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A Hope, Emily K Bergsland, Murat Fani Bozkurt, et al.
Page
of 9